Prevnar13
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
114 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pneumococcal infections | D011008 | EFO_0000772 | J13 | 11 | 14 | 20 | 3 | 4 | 48 |
| Infections | D007239 | EFO_0000544 | — | 3 | 4 | 3 | 3 | 1 | 13 |
| Pneumococcal pneumonia | D011018 | EFO_1001474 | J13 | 1 | 4 | 4 | 3 | — | 10 |
| Meningococcal infections | D008589 | EFO_0004249 | A39 | — | 1 | 7 | 1 | — | 9 |
| Communicable diseases | D003141 | — | — | 3 | 2 | 1 | 3 | — | 8 |
| Multiple myeloma | D009101 | — | C90.0 | 2 | 2 | — | 2 | — | 6 |
| Pneumonia | D011014 | EFO_0003106 | — | — | 1 | 1 | 3 | 1 | 6 |
| Plasma cell neoplasms | D054219 | — | — | 1 | 2 | — | 2 | — | 5 |
| Hepatitis b | D006509 | — | — | — | 1 | 2 | 1 | 1 | 5 |
| Lymphoma | D008223 | — | C85.9 | 1 | 4 | — | 1 | — | 5 |
Show 22 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | 2 | 5 | — | — | 9 |
| Streptococcal infections | D013290 | EFO_1001476 | — | — | 4 | 1 | — | — | 5 |
| Haemophilus influenzae type b | D019741 | — | — | — | 1 | 4 | — | — | 5 |
| Mumps | D009107 | — | B26 | — | 1 | 3 | — | — | 4 |
| Measles | D008457 | — | B05 | — | 1 | 3 | — | — | 4 |
| Rubella | D012409 | — | B06 | — | 1 | 3 | — | — | 4 |
| Virus diseases | D014777 | — | B34 | — | — | 3 | — | — | 3 |
| Bacterial infections | D001424 | — | A49 | — | — | 3 | — | — | 3 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | 1 | — | — | 2 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | — | 1 | — | — | 2 |
Show 3 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | 3 | — | — | 1 | 4 |
| Leukemia | D007938 | — | C95 | — | 2 | — | — | 1 | 3 |
| Lymphoid leukemia | D007945 | — | C91 | — | 2 | — | — | 1 | 3 |
| Follicular lymphoma | D008224 | — | C82 | 1 | 2 | — | — | — | 2 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 1 | 2 | — | — | — | 2 |
| B-cell lymphoma | D016393 | — | — | 1 | 2 | — | — | — | 2 |
| Meningitis | D008581 | HP_0001287 | G03 | — | 1 | — | — | 1 | 2 |
| Bacterial pneumonia | D018410 | EFO_1001272 | J15.9 | 1 | 2 | — | — | — | 2 |
| Prolymphocytic leukemia t-cell | D015461 | — | C91.6 | — | 1 | — | — | — | 1 |
| Lymphocytosis | D008218 | — | — | — | 1 | — | — | — | 1 |
Show 16 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lipodystrophy | D008060 | HP_0009125 | E88.1 | 1 | — | — | — | — | 1 |
| Hiv-associated lipodystrophy syndrome | D039682 | EFO_1001348 | — | 1 | — | — | — | — | 1 |
| Kidney transplantation | D016030 | — | — | 1 | — | — | — | — | 1 |
| Hiv | D006678 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Otitis | D010031 | — | — | — | — | — | — | 2 | 2 |
| Vaccine-preventable diseases | D000079263 | — | — | — | — | — | — | 2 | 2 |
| Mastoiditis | D008417 | HP_0000265 | H70.9 | — | — | — | — | 1 | 1 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | — | — | 1 | 1 |
| Intestinal diseases | D007410 | HP_0002242 | K63.9 | — | — | — | — | 1 | 1 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Prevnar13 – Pfizer
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use